DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: Even the fear of possible cardiac rejection [216] is limited—at least for patients with dystrophinopathies—because the missing/poor dystrophin present makes the production of antibodies against the deleted region of dystrophin gene very unlikely.